Skip to main content
. Author manuscript; available in PMC: 2012 Jun 1.
Published in final edited form as: Transpl Infect Dis. 2011 Mar 17;13(3):244–249. doi: 10.1111/j.1399-3062.2011.00624.x

Table 2.

Incidence of cytomegalovirus (CMV) disease by 1 year post transplant (n = 113) in D+ R− kidney transplant recipients who received antiviral prophylaxis

Outcome
No. (%)
CMV disease 29 (26)
 Syndrome 19 (66)
 Invasive disease 10 (34)
  Gastrointestinal tract 8 (80)
  Pneumonia 1 (10)
  Hepatitis 1 (10)

D+ R−, donor CMV seropositive, recipient CMV seronegative.